Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future
The economic burden of dementia was estimated as being US$ 604 billion in 2010. Now it is time for new guidelines in handling of neurodegenerative disorders. Optimistic versus Pessimistic Prognosis depends much on diagnostic and treatment approaches which healthcare will preferably adopt in the near...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Dordrecht :
Springer Netherlands : Imprint: Springer,
2013.
|
| Σειρά: | Advances in Predictive, Preventive and Personalised Medicine,
2 |
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- 1. What is this book series about?- 2. Preface
- 3. Introductory chapter
- 4. Individual predispositions in healthy vasospastic individuals: Patient profiling for targeted prevention of “down-stream” pathologies as cost-effective personalised medicine
- 5. Idiopathic REM sleep behavior disorder as a long-term predictor of neurodegenerative disorders
- 6. New animal models of progressive neurodegeneration: tools for developing predictive diagnostics and identifying presymptomatic therapeutic targets
- 7. Tau pathology: A selected view on the current status
- 8. The Use of Biomarkers for Prediction and Prevention of Alzheimer's and Parkinson's Diseases
- 9. Making clinical trials of Alzheimer’s disease delay-of-onset a reality by use of a prognostic genetic biomarker
- 10. An update on CSF biomarkers of Parkinson’s disease
- 11. Glaucomatous optic neuropathy: Risk assessment and potential targets for effective prevention and treatments tailored to the patient
- 12. Toward a personalized approach in amyotrophic lateral sclerosis: new developments in diagnosis, genetics, pathogenesis and therapies
- 13. Recent advances in ALS research: perspectives for personalized clinical application
- 14. Exercise in Multiple Sclerosis – an Integral Component of Disease Management
- 15. Bridging the Informatics Gap between Bench and Bedside: Implications to Neurodegenerative Diseases
- 16. Personalized Medicine In Rare Paediatric Neurometabolic Diseases.
